Technology Commercialization Program
The UTMB Technology Commercialization Program (TCP) provides seed funds to support the commercialization of discoveries created at UTMB Health. The funds for this program are made available from the UTMB Health President’s Royalty Fund. Through a partnership between the Chief Research Office and The Office of Technology Transfer, this program is usually offered twice a year, in the fall and spring.
NIH SBIR / STTR Grants
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America’s Seed Fund, are one of the largest sources of early-stage capital for technology commercialization in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization.
The Cancer Prevention & Research Institute of Texas (CPRIT) offers several funding opportunities for promising cancer research, product development, and prevention programs.
ITS Pilot Awards
As UTMB’s home for translational research, the ITS offers competitive pilot grants to projects that aim to improve the health of our community through innovation, team science, and the development, application, and evaluation of precision medicine approaches.
Office of Technology Transfer
The Office of Technology Transfer manages UTMB's Intellectual property assets, while promoting and encouraging scientific research. Its services include: Intellectual Property management, marketing and licensure of UTMB's Intellectual Property, business development and collaboration, trainings and workshops, agreement negotiation, and commercialization.
UTMB provides and supports numerous Core Research Facilities for its investigators and staff.
The MakerHealth Space is a place for the UTMB community to design, build, and prototype. It is s open to all UTMB staff and students to learn to work with 3D printing, laser cutting, textiles, electronics, general hand & power tools, and much more.
ITS Clinical Trials Studio
The Institute for Translational Sciences' Clinical Trials Studio is an initiative supported by a multidisciplinary team of accomplished clinical trialists aiming to assist UTMB investigators with beginning and refining their clinical trials. It assists researchers at any career level, and it provides feedback on trials at any stage of development. From its website, you can access information and forms related to project design, study recruitment, budget analyses, protocol development, and regulatory submissions.
UTMB's Research Services group facilitates the UTMB research mission, from funding identification through project completion by providing research-specific resources and education; promoting the responsible conduct of research; and advising and assisting with administrative policies and regulations. From its website, you can access information, forms, and systems related to each part of a research project's lifecycle.
Office of Clinical Research
The Office of Clinical Research is a multidisciplinary service organization, staffed by a team experienced in sponsored clinical research, that supports faculty with sponsored clinical trials and investigator-initiated clinical research projects. On its website, you can find research-related Standard Operating Procedures, forms, templates, and information regarding Confidentiality Disclosure Agreements and Clinical Trials Contracting.
Located in Houston’s Texas Medical Center, the GCC is one of the largest inter-institutional cooperatives in the world with a focus on building strong collaborative research groups and interdisciplinary training opportunities for PhD students and postdocs.
The GCC delivers important advances in bioscience research and training by empowering individuals to go beyond the limitations of any single institution, discipline or degree program. It includes seven partner institutions: Baylor College of Medicine, Rice University, University of Houston, University of Texas Health Science Center at Houston, University of Texas Medical Branch at Galveston, University of Texas MD Anderson Cancer Center, and the Institute of Biosciences & Technology at Texas A&M Health Science Center.
JLabs @ TMC
JLABS @ TMC links regional entrepreneurs to the global subject matter experts internally at Johnson & Johnson Innovation, including opportunities to discuss funding, access third-party services, attend educational events and meet with R&D experts from medical device, consumer healthcare product, and Janssen pharmaceutical teams. The JLABS @ TMC portfolio spans the breadth of life sciences with companies focused on oncology, therapeutics, pharma and medical device, turning Houston into the true third coast of innovation. To facilitate medical device research, JLabs features a full-scale prototyping space, including specialized software, electronics testing and assembly equipment, rapid fabrication, and 3D printing capabilities.
BioHouston, Inc. is a non-profit tax-exempt [501(c)(3)] corporation founded by Houston area academic/research institutions. It aims to establish the Houston region as a vigorous global competitor in life science and biotechnology commercialization. Its mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization.
NCATS Chemical Genomics Center
The NCATS Chemical Genomics Center (NCGC), formerly known as the NIH Chemical Genomics Center, was created in 2008 as a comprehensive screening center in the Molecular Libraries Probe Production Centers Network, part of the NIH Common Fund’s Molecular Libraries Program. The NCGC aims to translate the discoveries of the Human Genome Project into biology and disease insights and ultimately new therapeutics through small molecule assay development, high-throughput screening, informatics, and chemistry. NCGC staff collaborate with more than 200 investigators at NIH and in the academic, biopharmaceutical, and nonprofit sectors to generate probes for studying a diverse cross-section of human biology, focusing specifically on new targets and untreatable diseases.